Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients [Phase 1, Phase 2]

View source ↗

Summary

A multi-phase clinical trial is evaluating the safety and pharmacokinetics of regadenoson in pediatric patients; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

Sponsor: GE Healthcare | Conditions: Myocardial Ischemia, Coronary Artery Disease | Phase 1, Phase 2 | Status: RECRUITING